Moneycontrol
HomeNewsBusinessCoronavirus pandemic | Banks see a big jump in social media chatter as customers take to Twitter, Facebook
Trending Topics

Coronavirus pandemic | Banks see a big jump in social media chatter as customers take to Twitter, Facebook

From queries on loan moratorium to KYC applications, banks flooded with queries on Facebook, Twitter and other social media.

May 13, 2020 / 14:43 IST
Story continues below Advertisement

Social media has finally arrived on the Indian banking scene.

More and more people are taking to Twitter, Facebook and other social media channels to get in touch with their banks to ask about loans, lodge complaints and even explore business opportunities as the nationwide lockdown to curb the coronavirus enters Day 50.

Story continues below Advertisement

While the change has been going on for a while, the nationwide shutdown has accelerated the shift away from traditional phone and branch banking to digital channels.

“During the initial part of the lockdown period, we saw a 50 percent jump in social media queries compared to February, with Twitter and Facebook being the two most popular channels,” said Puneet Kapoor, president, products, alternate channels and customer experience delivery, Kotak Mahindra Bank.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show